Takeda Pharmaceutical
TAK
#461
Rank
ยฃ41.20 B
Marketcap
ยฃ12.90
Share price
-0.40%
Change (1 day)
19.11%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of March 2026 : ยฃ2.97 Billion

According to Takeda Pharmaceutical's latest financial reports the company has ยฃ2.97 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2026-03-31ยฃ3.03 B44.85%
2025-03-31ยฃ2.09 B-15.28%
2024-03-31ยฃ2.47 B-26.5%
2023-03-31ยฃ3.36 B-38.48%
2022-03-31ยฃ5.46 B-16.77%
2021-03-31ยฃ6.56 B34.09%
2020-03-31ยฃ4.89 B-2.39%
2019-03-31ยฃ5.01 B99.63%
2018-03-31ยฃ2.51 B-6.74%
2017-03-31ยฃ2.69 B-22.22%
2016-03-31ยฃ3.46 B-13.54%
2015-03-31ยฃ4.00 B-18.98%
2014-03-31ยฃ4.94 B26.16%
2013-03-31ยฃ3.92 B12.87%
2012-03-31ยฃ3.47 B-46.88%
2011-03-31ยฃ6.54 B6.28%
2010-03-31ยฃ6.15 B15.72%
2009-03-31ยฃ5.31 B-35.14%
2008-03-31ยฃ8.20 B5.3%
2007-03-31ยฃ7.78 B-15.19%
2006-03-31ยฃ9.18 B22.37%
2005-03-31ยฃ7.50 B9.67%
2004-03-31ยฃ6.84 B11.3%
2003-03-31ยฃ6.14 B31.78%
2002-03-31ยฃ4.66 B15.55%
2001-03-31ยฃ4.03 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
ยฃ16.34 B 449.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.17 B 73.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ9.69 B 225.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.92 B 199.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ4.75 B 59.76%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ4.22 B 41.96%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ3.37 B 13.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
ยฃ0.91 B-69.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
ยฃ0.69 B-76.61%๐Ÿ‡ฎ๐Ÿ‡ณ India